EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 105 filers reported holding EPIZYME INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $436,000 | -44.7% | 379,300 | +20.3% | 0.00% | -50.0% |
| Q4 2021 | $789,000 | +335.9% | 315,400 | +1416.3% | 0.00% | – |
| Q1 2021 | $181,000 | -14.2% | 20,800 | +7.2% | 0.00% | -100.0% |
| Q4 2020 | $211,000 | -89.7% | 19,400 | -88.7% | 0.00% | -83.3% |
| Q3 2020 | $2,054,000 | +75.0% | 172,200 | +135.6% | 0.01% | +100.0% |
| Q2 2020 | $1,174,000 | +1444.7% | 73,100 | +489.5% | 0.00% | – |
| Q4 2018 | $76,000 | – | 12,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 9,166,667 | $79,842,000 | 29.97% |
| Foresite Capital Management III, LLC | 998,278 | $8,695,000 | 7.64% |
| KPCB XIII Associates, LLC | 3,838,166 | $33,430,000 | 6.87% |
| Burrage Capital Management LLC | 564,555 | $4,917,000 | 3.98% |
| Palo Alto Investors LP | 6,856,513 | $59,720,000 | 3.40% |
| MPM BioImpact LLC | 2,331,534 | $20,308,000 | 2.55% |
| Foresite Capital Management II, LLC | 1,000,002 | $8,710,000 | 2.00% |
| Foresite Capital Management I, LLC | 293,759 | $2,559,000 | 1.29% |
| Redmile Group, LLC | 8,824,366 | $76,860,000 | 1.08% |
| Rock Springs Capital Management LP | 2,802,954 | $24,414,000 | 0.53% |